v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash $ 2,351 $ 3,599
Accounts receivable, net of allowance of $75 and $50, respectively 3,280 3,603
Note receivable 1,400
Current licensing fees receivable 225 150
Inventories, net 4,689 2,657
Prefunded insurance premiums from financing 71 214
Prepaid expenses and other current assets 996 1,224
Deferred financing costs 415 415
Total current assets 12,027 13,262
Long-term licensing fees receivable 1,521 1,647
Fixed assets, net of accumulated depreciation of $754 and $583, respectively 183 321
Total assets 13,731 15,230
Current liabilities:    
Accounts payable 5,340 6,378
Accrued expenses 3,376 3,960
Revolving credit facility and loans 3,721 3,022
Insurance premium financing 71 214
Promissory notes 190
Total current liabilities 12,508 13,764
Total liabilities 12,508 13,764
Commitments and contingencies (Note 14)
Shareholders’ equity:    
Common stock, no par value:Authorized — 800,000,000. Issued and outstanding shares — 118,780,917 shares and 118,227,478 shares, respectively 96,254 95,895
Accumulated other comprehensive income 232 299
Accumulated deficit (95,263) (94,728)
Total shareholders’ equity 1,223 1,466
Total liabilities and shareholders’ equity $ 13,731 $ 15,230